Patent · US Active

Antibody drug conjugates

US10117953B2 · kind B2 · utility

2Cited by

35References

15Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Tinya Abrams · Richmond, US
Steven Bruce Cohen · San Diego, US
Christie P. Fanton · Oakland, US
Thomas Huber · Basel, CH
Kathy Miller · San Francisco, US
Siew Ho Schleyer · Emeryville, US
Kathrin Ulrike Tissot-Daguette · Schwanau, DE
Catrin Finner · Planegg, DE

Key dates

Filing date	Oct 3, 2016
Grant date	Nov 6, 2018
Priority date	—
Expiry date	Oct 3, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to anti-cKIT antibodies, antibody fragments, antibody drug conjugates, and their uses for the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.